Patent · US Active

Epirubicin derivatives

US8877720B2 · kind B2 · utility

2Cited by
0References
14Claims
0Family size

Assignees

Inventor

Key dates

Filing dateNov 3, 2010
Grant dateNov 4, 2014
Priority date—
Expiry dateMar 3, 2031

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07H19/048
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed are compounds represented by formula (I), pharmaceutically acceptable salts thereof, solvates thereof, and solvates of the pharmaceutically acceptable salts thereof,wherein R1, R2, R3, R4, W andare as defined in the present application.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.